SPL starpharma holdings limited

The big picture - why nasal sprays were doomed

  1. 1,328 Posts.
    lightbulb Created with Sketch. 289

    Will Kennedy review of US FDA vaccine committee being independant of BIG PHARHA influence cause genuine change and include support of regulator controlled trials and studies like UK MHRA did for VIRALEZE™ in UK NHS Hospital

    WHY DIDN’T WHO CONTROL THE BIG PICTURE AND FALL FOR WARLORD BIG PHARMA PROFITEERING

    It was a simple formula when COVID-19 began in 2020:


    1️⃣ Find a vaccine

    2️⃣ Find a treatment


    The strategy: vaccinate the world and treat the sick — herd immunity would follow.


    But it was flawed. COVID-19 wasn’t like polio, measles, smallpox, or shingles — where one shot gives long-term protection or leads to elimination.


    COVID is a respiratory virus like flu, RSV, or the common cold. No vaccine has ever lasted even a year for these. Over an 80-year lifespan, that means 100+ muscle jabs.


    In 2020, VIRALEZE™ emerged — a preventive nasal spray that kills COVID and other viruses on contact. Like sunscreen or toothpaste, regular use could protect entire communities.


    But in 2021, rushed mRNA vaccines needed global rollout and guaranteed markets. Big Pharma used its full influence: lobbying, donations, committee positions, media control. This battle couldn’t be lost.


    Manufacturing scale gave Big Pharma a monopoly — any threat to profit (like cheap, broad preventives) had to be stopped.


    So prevention messaging was restricted to the visible: handwashing, masks, surface wipes — while denying airborne spread and censoring nasal sprays.


    A market was secured: repeat jabs every year, forever.


    By 2021, info control (via TNI and government “truth” campaigns) ensured that simple, safe alternatives like VIRALEZE™ were buried.


    There are thousands of pages to this story. Perhaps one day a corruption commission will expose it.


    Regulators must serve public health, not corporate profit. Science must be independent — not outsourced to pharma-funded trials

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
9.4¢
Change
0.004(3.87%)
Mkt cap ! $39.31M
Open High Low Value Volume
9.0¢ 9.4¢ 9.0¢ $21.86K 237.3K

Buyers (Bids)

No. Vol. Price($)
2 120141 9.2¢
 

Sellers (Offers)

Price($) Vol. No.
9.4¢ 13999 2
View Market Depth
Last trade - 16.10pm 13/06/2025 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.